drugset / Trial / NCT03558984

D-PLEX 302: Efficacy and Safety of D-PLEX in the Prevention of Sternal Infection Post Cardiac Surgery

NCT03558984

Phase 3 Terminated 2 enrolled PolyPid Ltd.
RandomizedParallel-groupDouble-blindPrevention

Summary

Prospective, Multinational, Multicenter, Randomized, Parallel Controlled, Two arms, Single Blind, Study to Assess the Efficacy and Safety of D-PLEX Administered Concomitantly with the Standard of Care (SOC) IV Prophylactic Antibiotic Treatment vs. SOC in Prevention of Post-Cardiac Surgery Sternal Infections. Study to assess D-PLEX efficacy and safety in preventing sternal infections over a period of 90 days (3 months) post cardiac surgery with median sternotomy, in patients with high risk for infection compared to the control arm.

Timeline

Start
2019-12-17
Primary completion
2022-10-24
Completion
2022-10-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxycycline Small molecule Other

Indications

No indication recorded.